DOCS vs NBIX
Doximity Inc (DOCS) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
Doximity Inc (DOCS) is a health information services company listed on US.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported DOCS revenue for 2025-03-31 was $570.4M. Net income was $223.2M. Revenue was up 20.0% from 2024-03-31 to 2025-03-31. DOCS currently screens at market cap $3.77B and trailing P/E 21.0.
Latest reported NBIX revenue for 2024-12-31 was $2.36B. Net income was $341.3M. Revenue was up 24.8% from 2023-12-31 to 2024-12-31. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
DOCS currently screens at market cap $3.77B and trailing P/E 21.0. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the DOCS and NBIX stock pages for the full models.
Not investment advice.